Edwards Lifesciences Free Cash Flow 2010-2024 | EW
Edwards Lifesciences annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Edwards Lifesciences free cash flow for the quarter ending December 31, 2024 was 467.20, a year-over-year.
- Edwards Lifesciences free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.
- Edwards Lifesciences annual free cash flow for 2023 was $0.643B, a 33.98% decline from 2022.
- Edwards Lifesciences annual free cash flow for 2022 was $0.974B, a 30.77% decline from 2021.
- Edwards Lifesciences annual free cash flow for 2021 was $1.406B, a 117.26% increase from 2020.
| Edwards Lifesciences Annual Free Cash Flow | |
|---|---|
| 2023 | 642.80 |
| 2022 | 973.60 |
| 2021 | 1,406.30 |
| 2020 | 647.30 |
| 2019 | 928.50 |
| 2018 | 688.00 |
| 2017 | 832.60 |
| 2016 | 528.30 |
| 2015 | 447.00 |
| 2014 | 942.50 |
| 2013 | 366.00 |
| 2012 | 256.10 |
| 2011 | 235.50 |
| 2010 | 196.20 |
| 2009 | 199.20 |
| Edwards Lifesciences Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | 467.20 |
| 2024-06-30 | 167.30 |
| 2024-03-31 | -118.80 |
| 2023-12-31 | 642.80 |
| 2023-09-30 | 594.50 |
| 2023-06-30 | 238.30 |
| 2023-03-31 | 252.60 |
| 2022-12-31 | 973.60 |
| 2022-09-30 | 759.70 |
| 2022-06-30 | 509.70 |
| 2022-03-31 | 220.60 |
| 2021-12-31 | 1,406.30 |
| 2021-09-30 | 1,122.50 |
| 2021-06-30 | 651.30 |
| 2021-03-31 | 194.50 |
| 2020-12-31 | 647.30 |
| 2020-09-30 | 360.70 |
| 2020-06-30 | 247.90 |
| 2020-03-31 | 124.90 |
| 2019-12-31 | 928.50 |
| 2019-09-30 | 597.10 |
| 2019-06-30 | 235.90 |
| 2019-03-31 | -40.70 |
| 2018-12-31 | 688.00 |
| 2018-09-30 | 452.70 |
| 2018-06-30 | 195.50 |
| 2018-03-31 | 108.10 |
| 2017-12-31 | 832.60 |
| 2017-09-30 | 520.60 |
| 2017-06-30 | 252.10 |
| 2017-03-31 | 112.40 |
| 2016-12-31 | 528.30 |
| 2016-09-30 | 390.40 |
| 2016-06-30 | 232.60 |
| 2016-03-31 | 79.40 |
| 2015-12-31 | 447.00 |
| 2015-09-30 | 380.70 |
| 2015-06-30 | 204.20 |
| 2015-03-31 | 52.50 |
| 2014-12-31 | 942.50 |
| 2014-09-30 | 880.70 |
| 2014-06-30 | 886.60 |
| 2014-03-31 | 124.60 |
| 2013-12-31 | 366.00 |
| 2013-09-30 | 272.50 |
| 2013-06-30 | 162.90 |
| 2013-03-31 | 64.30 |
| 2012-12-31 | 256.10 |
| 2012-09-30 | 185.10 |
| 2012-06-30 | 76.90 |
| 2012-03-31 | -48.70 |
| 2011-12-31 | 235.50 |
| 2011-09-30 | 168.10 |
| 2011-06-30 | 68.30 |
| 2011-03-31 | 1.00 |
| 2010-12-31 | 196.20 |
| 2010-09-30 | 122.40 |
| 2010-06-30 | 40.90 |
| 2010-03-31 | 7.10 |
| 2009-12-31 | 199.20 |
| 2009-09-30 | 151.50 |
| 2009-06-30 | 30.20 |
| 2009-03-31 | -20.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.937B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $212.123B | 97.31 |
| Thermo Fisher Scientific (TMO) | United States | $203.433B | 24.33 |
| Alcon (ALC) | Switzerland | $44.417B | 29.72 |
| IDEXX Laboratories (IDXX) | United States | $36.400B | 41.66 |
| DexCom (DXCM) | United States | $34.790B | 53.98 |
| IQVIA Holdings (IQV) | United States | $34.065B | 18.87 |
| Mettler-Toledo (MTD) | United States | $26.604B | 30.90 |
| Waters (WAT) | United States | $21.953B | 31.15 |
| STERIS (STE) | Ireland | $21.550B | 24.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.044B | 0.00 |
| Hologic (HOLX) | United States | $14.190B | 15.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.755B | 14.12 |
| Globus Medical (GMED) | United States | $11.429B | 28.94 |
| Sysmex ADR (SSMXY) | Japan | $11.267B | 35.33 |
| Penumbra (PEN) | United States | $10.311B | 101.00 |
| Masimo (MASI) | United States | $9.707B | 46.97 |
| Glaukos (GKOS) | United States | $8.447B | 0.00 |
| Teleflex (TFX) | United States | $7.776B | 12.40 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.679B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.528B | 0.00 |
| Veracyte (VCYT) | United States | $3.186B | 95.61 |
| Nihon Kohden (NHNKY) | Japan | $2.705B | 14.78 |
| LivaNova (LIVN) | United Kingdom | $2.589B | 14.95 |
| TransMedics (TMDX) | United States | $2.422B | 76.79 |
| Elekta AB (EKTAY) | Sweden | $2.392B | 21.50 |
| Tandem Diabetes Care (TNDM) | United States | $2.198B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.866B | 9.75 |
| Alphatec Holdings (ATEC) | United States | $1.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.291B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 83.50 |
| RxSight (RXST) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.798B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.792B | 17.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.762B | 12.94 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.711B | 0.00 |
| IRadimed (IRMD) | United States | $0.700B | 36.82 |
| SiBone (SIBN) | United States | $0.687B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.628B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.521B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.505B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.460B | 24.23 |
| AngioDynamics (ANGO) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| NeuroPace (NPCE) | United States | $0.367B | 0.00 |
| CVRx (CVRX) | United States | $0.366B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.287B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.132B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.127B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 13.77 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 30.14 |
| Microbot Medical (MBOT) | United States | $0.057B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |